| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.6204 | 35 |
| GSM780708 | Untreated after 4 days (C2_1) | 38.881 | 4 |
| GSM780709 | Untreated after 4 days (C3_1) | 41.3848 | 11 |
| GSM780719 | Untreated after 4 days (C1_2) | 49.7227 | 48 |
| GSM780720 | Untreated after 4 days (C2_2) | 51.8986 | 54 |
| GSM780721 | Untreated after 4 days (C3_2) | 55.9978 | 61 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 49.2303 | 46 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 43.3227 | 19 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.837 | 17 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 50.1971 | 49 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 55.1382 | 60 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.9878 | 37 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 45.4085 | 29 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.2163 | 38 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 48.4519 | 43 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.0676 | 41 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 61.263 | 65 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 55.9963 | 61 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.5901 | 39 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.5118 | 34 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 49.5686 | 47 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.6335 | 30 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.6161 | 25 |